Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 1, 2005, Pages 119-122

  Sompolinsky, David ^a,b   Nitzan, Yeshayahu ^a   Tetry, Shaul ^a,b   Wolk, Moshe ^c   Vulikh, Israel ^b   Barendorff Kerrn, Mette ^d   Sandvang, Dorthe ^d   Hershkovits, Gitit ^a   Katcoff, Don J ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b Department of Obstetrics   (Israel)

^c Ministry of Health Central Laboratories   (Israel)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

E. coli; Enterobacteriaceae; Extended spectrum lactamases

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PLASMID DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DNA PURIFICATION; ENTEROBACTER INFECTION; ENZYME DEGRADATION; EPIDEMIC; ESCHERICHIA COLI; HUMAN; INTEGRON; ISRAEL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PHYLOGENY; PLASMID; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SEROTYPE;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GERIATRICS; HOSPITALIZATION; HUMANS; INTEGRONS; ISRAEL; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SEROTYPING;

EID: 13244283032     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh517     Document Type: Article

References (10)

1. Sturenburg, E. & Mack, D. (2003). Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Journal of Infection 47, 273-95.
2. Gniadkowski, M. (2001). Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clinical Microbiology and Infection 7, 597-608.
3. Borer, A., Gilad, J., Menashe, G. et al. (2002). Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Medical Science Monitor 8, CR44-7.
4. Navon-Venezia, S., Hammer-Munz, O., Schwartz, D. et al. (2003). Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. Journal of Clinical Microbiology 41, 155-8.
5. Wolk, M., Valinsky, L., Sompolinsky, D. et al. (2004). Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel. FEMS Microbiology Letters, 239, 249-54.
6. Slucky-Shraga, I., Wolk, M., Volis, S. et al. (2000). Multiresistant Escherichia coli from elderly patients. Harefuah 139, 25-9, 79.
7. Orskov, F. & Orskov, I. (1984). Serotyping of Escherichia coli. Methods in Microbiology 14, 43-112.
8. Saladin, M., Cao, V. T., Lambert, T. et al. (2002). Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiology Letters 209, 161-8.
9. CTX-M-2 in Salmonella enterica serovar Infantis. Antimicrobial Agents and Chemotherapy 46, 2257-61.
10. Allmansberger, R., Brau, B. & Piepersberg, W. (1985). Genes for gentamicin-(3)-N-acetyl-transferases III and IV. II. Nucleotide sequences of three AAC(3)-III genes and evolutionary aspects. Molecular and General Genetics 198, 514-20.